PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Lactohale 206, a new tool for QbD for Dry Powder Inhalation

The DFE Pharma product portfolio for Dry Powder Inhalation contains a full range of lactose grades with different properties, which can be further optimised in collaboration with our customers. DFE Pharma proudly presents you the latest high-quality inhalation grade lactose: Lactohale® 206, a coarse milled alpha-monohydrate lactose without any fine lactose particles.
The mean particle size of this product can be tightly controlled between 75 and 95 µm, by milling to match the customer’s requirements.
The application of Lactohale® 206 provides a tool to explore the Quality-by-Design space of their Dry Powder Inhalation formulation: R&D teams can further optimise their inhaled formulation for flow and deposition by blending Lactohale® 206 with one of the fine grades of DFE Pharma (for example with Lactohale® 210, 220, 230 or 300). Lactohale® 206 is therefore especially of interest for formulators who are in early stage of development process or others who want to explore the design space of their formulation.
Lactohale® 206 is available as a standard grade or can be customised on request, to meet your specific requirements for your DPI formulation. For more information or to request a sample, please visit us at www.dfepharma.com.
 

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026